Company: ARTL
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001640334-25-002022
Chunk: 67

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-11-12
Form: 10-Q
Item: Part I, Item 2
Chunk 67
---
 filed with the SEC on May 11, 2023)3.2 Certificate of Change (incorporated by reference to Exhibit 3.1 of the Company’s Form 8-K filed with the SEC on June 13, 2025)3.3 Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 of the Company’s Form 8-K filed with the SEC on April 21, 2023)3.4Certificate of Amendment to Bylaws (incorporated by reference to Exhibit 3.1 of the Company’s Form 8-K filed with the SEC on September 10, 2025)4.1 Form of Pre-Funded Warrant (incorporated by reference to Exhibit 4.1 of the Company’s Form 8-K filed with the SEC on September 5, 2025)4.2 Form of Pre-Funded Warrant (incorporated by reference to Exhibit 4.1 of the Company’s Form 8-K filed with the SEC on October 1, 2025)10.1 At-The-Market Offering Agreement by and among the Artelo Biosciences, Inc. and R.F. Lafferty & Co., Inc., dated as of July 18, 2025 (incorporated by reference to Exhibit 1.1 of the Company’s Form 8-K filed with the SEC on July 18, 2025)10.2 Form of Securities Purchase Agreement by and between Artelo Biosciences, Inc. and the investors named therein (incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K filed with the SEC on August 4, 2025)10.3 Consulting Agreement by and between Artelo Biosciences, Inc. and ABK Labs, Inc., dated August 1, 2025 (incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K filed with the SEC on August 7, 2025)10.4 Form of Termination and Mutual Release Agreement by and between Artelo Biosciences, Inc. and the investors named therein (incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K filed with the SEC on August 20, 2025)10.5 Termination Agreement by and between Artelo Biosciences, Inc. and ABK Labs,